Autonomic Nervous System, Fatigue and Intolerance to Physical Training, and Overtraining in High-Level Athletes

Autonomic Nervous System, Fatigue and Intolerance to Physical Training, and Overtraining in High-Level Athletes. A Multicentre Study

Sports training aims to enhance an athlete's performance (overcompensation). To do that, the athlete must go through periods of fatigue and lower performance (overreaching). When the training plan is balanced, this fatigue is short and reversible.If the training load is too heavy or if recuperation periods are too short, it can lead to persistence fatigue that may only be reversible in the long term. This state of fatigue is part of the broader clinical picture of overtraining, which includes stark changes in performance as well as mood and sleep disorders. Many prediction and characterization methods based on biological markers have been evaluated, but they have not been put into practice in sports training due to obstacles such as reliability, interindividual variability and high costs. This study aims to evaluate a new approach based on the variability of an individual's heart rate (RR variability), which is a way of measuring autonomic nervous system (ASN) activity. It is non-invasive, low-cost, and has already proven useful in athlete health monitoring.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The investigators propose to describe the variation of these ANS regulation factors over a full year, in a population of high-level athletes, in order to measure changes in regulation which may be predictive of potential fatigue and intolerance to physical training, if such a syndrome came to be observed among the study group.

Study Type

Observational

Enrollment (Actual)

131

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Albertville, France, 73200
        • CH Albertville Moutiers
      • Besancon, France, 25000
        • CHU de Besançon
      • Bobigny, France, 93000
        • Université Paris XIII
      • Grenoble, France, 38000
        • CHU de Grenoble
      • Pointe A Pitre, France, 97110
        • CHU de Pointe à Pitre
      • Premanon, France, 39400
        • CNSN Centre médical de Prémanon
      • Saint-Etienne, France, 42000
        • CHU de Saint-Etienne
      • Toulouse, France, 31000
        • CREPS Toulouse Midi Pyrénées

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

High-level athlete, enrolled in a Ministry-recognized Pôle

Description

Inclusion Criteria:

  • High-level athlete, enrolled in a Ministry-recognized Pôle
  • Participant signed the informed consent form

Exclusion Criteria:

  • Confirmed current overtraining syndrome
  • Known pregnancy on inclusion
  • Athlete using cardio-inhibitor or cardio-accelerator drugs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
high-level athletes
High-level athlete, enrolled in a Ministry-recognized Pôle
This ANS activity is measured by nocturnal heart rates records with Holter ECG.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Autonomic nervous system (ANS) activity
Time Frame: One year
This ANS is mesured during the night using a spectral analysis of nocturnal heart rate variability.
One year
Fatigue and physical training
Time Frame: One year
Fatigue and physical training potetially due to overtraining, suspected based on a very significant, long-term worsening in performance
One year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
kinetic of the ANS activity
Time Frame: Every 15 days (from the iclusion to one year)
ANS is mesured during the night using a spectral analysis of nocturnal heart rate variability
Every 15 days (from the iclusion to one year)
orthostasis test
Time Frame: Every 15 days (from inclusion to one year)
ANS activity measurements (RR variability) during active orthostasis transition on waking up in the morning
Every 15 days (from inclusion to one year)
French Society of Sports Medicine questionnaire
Time Frame: Every 15 days (from inclusion to one year)
The questionnaire was designed to detect early signs of overtraining. It includes 54 yes/no questions. Subjects who answer "yes" to more than 20 questions are considered at risk for overtraining.
Every 15 days (from inclusion to one year)
POMS (Profile of Mood States) questionnaire
Time Frame: Every 3 months (from inclusion to inclusion)
Every 3 months (from inclusion to inclusion)
Sleep quality questionnaire
Time Frame: Every 3 months (from inclusion to one year)
The questionnaire is self-administered. It includes two parts. The first part consists of several questions regarding sleep during the previous night. The second part aims to evaluate the physical exertion load during the previous day's training session(s). Participants will fill one questionnaire/day for a whole week. Each questionnaire period must coincide with a training period (interseason, volume, intensity, or competition.)
Every 3 months (from inclusion to one year)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Xavier BIGARD, MD PhD, Institut de Recherche Biomédicales des Armées

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2010

Primary Completion (ACTUAL)

December 1, 2012

Study Completion (ACTUAL)

December 1, 2012

Study Registration Dates

First Submitted

October 31, 2011

First Submitted That Met QC Criteria

November 1, 2011

First Posted (ESTIMATE)

November 2, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

March 6, 2013

Last Update Submitted That Met QC Criteria

March 5, 2013

Last Verified

March 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 0908073
  • 2009-A00674-53 (OTHER: AFSSAPS)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fatigue

Clinical Trials on ANS activity

Subscribe